(Q50352463)

English

Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.

scientific article published on 3 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy. (English)

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

radiation therapy

0 references

quality of life

1 reference

based on heuristic

inferred from title

author name string

Tai-Lin Huang

1

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Chih-Yen Chien

2

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Wen-Ling Tsai

3

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Kuan-Cho Liao

4

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Shang-Yu Chou

5

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Hsin-Ching Lin

6

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Sheng Dean Luo

7

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Tsair-Fwu Lee

8

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Chien-Hung Lee

9

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Fu-Min Fang

10

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

publication date

3 June 2015

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

38 Suppl 1

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

E1026-32

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methods.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Quality of life in patients of nasopharyngeal carcinoma: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

How to validate clinically important change in health-related functional status. Is the magnitude of the effect size consistently related to magnitude of change as indicated by a global question rating?

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Can intensity-modulated radiotherapy preserve oral health-related quality of life of nasopharyngeal carcinoma patients?

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Intensity-modulated radiotherapy is associated with improved global quality of life among long-term survivors of head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Chinese nasopharyngeal carcinoma patients treated with radiotherapy: association between satisfaction with information provided and quality of life.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Oral health-related quality of life in southern Chinese following radiotherapy for nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Quality of life of nasopharyngeal carcinoma survivors in Mainland China.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Multivariate analysis of quality of life outcome for nasopharyngeal carcinoma patients after treatment.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Quality of life in survivors of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

21 January 2018

Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

7 January 2021

based on heuristic

inferred from DOI database lookup

Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: results of a prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

7 January 2021

based on heuristic

inferred from DOI database lookup

Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

7 January 2021

based on heuristic

inferred from DOI database lookup

Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules

1 reference

https://api.crossref.org/works/10.1002%2FHED.24150

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HED.24150

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

1 reference

Europe PubMed Central

6 March 2018

http://europepmc.org/abstract/MED/26041548

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50352463&oldid=1456104383"